Lataa...
The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
Cancer immunotherapists have been searching for biomarkers predicting patient responses to PD-1/PD-L1 blockade in neoplastic cells as well as in the immune system. Now, accumulating evidence indicates that the composition of the intestinal microflora has a major impact on patient prognosis. Here, we...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980343/ https://ncbi.nlm.nih.gov/pubmed/29872574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1434468 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|